Arrowhead Pharmaceuticals approved inducement grants under NASDAQ Rule 5635(c)(4) on July 25, 2025.
1 report, 1 independent
Updated Jul 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Arrowhead Pharmaceuticals approved inducement grants under NASDAQ Rule 5635(c)(4) on July 25, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Arrowhead Pharmaceuticals
biopharmaceutical company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireArrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) PASADENA, Calif., July 24, 2025--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announc